Effect of dopaminergic substances on sleep/wakefulness in saline – and MPTP-treated mice
Abstract
Sleep/wakefulness (S/W) disorders are frequent in Parkinson's disease (PD). The underlying causes have yet to be elucidated but dopaminergic neurodegenerative lesions seem to contribute to appearance of the disorders and anti-Parkinsonian medication is known to accentuate S/W problems. Hence, we reasoned that studying the acute effect of dopaminergic compounds on S/W in an animal model of PD might improve our knowledge of S/W regulation in the context of partial dopaminergic depletion. To this end, we tested the effect of levodopa (l-dopa), pergolide (a mixed D(2)/D(1) agonist) and lisuride (a D(2) agonist) on S/W recordings in MPTP-treated mice, in comparison with controls. Our results showed that dopaminergic compounds modify S/W amounts in both control and MPTP mice. Wakefulness amounts are greater in MPTP mice after l-dopa (50 mg kg(-1)) and lisuride (1 mg kg(-1)) injections compared with control mice. Moreover, the paradoxical sleep latency was significantly longer in MPTP mice after high-dose l-dopa administration. Our observations suggest that the actions of both l-dopa and lisuride on S/W differ slightly in MPTP mice relative to controls. Hence, MPTP-induced partial DA depletion may modulate the effect of dopaminergic compounds on S/W regulation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sleep changes in MPTP-treated primates are more severe than those found in the mouse model.
“These changes are more severe compared to those found in the mouse model (Fifel et al., 2016, Laloux et al., 2008).”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Laloux et al., 2008
Cites
1 retracted
Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin Neurons
Alberto, C. O., Trask, R. B., Quinlan, M. E., & Hirasawa, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1819-06.2006 · Cited by 56 · see citing works
RetractedNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · see citing works
Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
Frucht, S. J., Rogers, J., Greene, P., Gordon, M. F., & Fahn, S. (1999) · Neurology · doi:10.1212/wnl.52.9.1908 · Cited by 691 · see citing works
Fuller, P. M., Gooley, J. J., & Saper, C. B. (2006) · Journal of Biological Rhythms · doi:10.1177/0748730406294627 · Cited by 596 · see citing works
From waking to sleeping: neuronal and chemical substrates
Jones, B. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.09.009 · Cited by 577 · see citing works
Hypocretin-1 Modulates Rapid Eye Movement Sleep through Activation of Locus Coeruleus Neurons
Bourgin, P., Huitrón‐Reséndiz, S., Spier, A. D., Fabre, V., Morte, B., Criado, J. R., Sutcliffe, J. G., Henriksen, S. J., & de Lecea, L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07760.2000 · Cited by 508 · see citing works
Analysis of Covariance Using the Rank Transformation
Conover, W. J., & Iman, R. L. (1982) · Biometrics · doi:10.2307/2530051 · Cited by 448 · see citing works
The Nighttime Problems of Parkinsonʼs Disease
Lees, A. J., Blackburn, N. A., & Campbell, V. L. (1988) · Clinical Neuropharmacology · doi:10.1097/00002826-198812000-00004 · Cited by 444 · see citing works
Hallucinations, REM sleep, and Parkinson’s disease
Arnulf, I., Bonnet, A.-M., Damier, P., Bejjani, B.-P. W., Seilhean, D., Derenne, J., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.2.281 · Cited by 439 · see citing works
The involvement of dopamine in the modulation of sleep and waking
Monti, J. M., & Monti, D. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.08.003 · Cited by 419 · see citing works
Nishino, S., & Kanbayashi, T. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.03.004 · Cited by 376 · see citing works
Léna, I., Parrot, S., Deschaux, O., Muffat‐Joly, S., Sauvinet, V., Renaud, B., Suaud‐Chagny, M. ‐., & Gottesmann, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20602 · Cited by 322 · see citing works
Dopaminergic Control of Sleep–Wake States
Dzirasa, K., Ribeiro, S. T. G., Costa, R. M., Santos, L. M., Lin, S., Grosmark, A., Sotnikova, T. D., Gainetdinov, R. R., Caron, M. G., & Nicolelis, M. A. L. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1767-06.2006 · Cited by 313 · see citing works
Antidepressants and their effect on sleep
Mayers, A., & Baldwin, D. S. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.726 · Cited by 313 · see citing works
Sleep and Sleep Regulation in Normal and Prion Protein-Deficient Mice
Tobler, I., Deboer, T., & Fischer, M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01869.1997 · Cited by 296 · see citing works
Sleep: Neurotransmitters and neuromodulators
(1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90048-7 · Cited by 282 · see citing works
Daytime sleepiness in Parkinson’s disease
Rye, D. B., Bliwise, D. L., Dihenia, B., & Gurecki, P. (2000) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2000.00201.x · Cited by 260 · see citing works
Excessive daytime sleepiness in parkinsonism
Arnulf, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.01.001 · Cited by 235 · see citing works
Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD
Rye, D. B., & Jankovic, J. J. (2002) · Neurology · doi:10.1212/wnl.58.3.341 · Cited by 209 · see citing works
Sleep attacks and Parkinson's disease treatment
Ferreira, J., Galitzky, M., Montastruc, J., & Rascol, O. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02119-x · Cited by 199 · see citing works
Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.
Nishino, S., Mao, J., Sampathkumaran, R., & Shelton, J. (1998) · PubMed · Cited by 187 · see citing works
Boutrel, B., Franc, B., Hen, R., Hamon, M., & Adrien, J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03204.1999 · Cited by 177 · see citing works
Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat
Monti, J. M., Hawkins, M., Jantos, H., D'Angelo, L., & Fern�ndez, M. (1988) · Psychopharmacology · doi:10.1007/bf00181955 · Cited by 176 · see citing works
Sleep Disturbances in Children with Attention Deficit Hyperactivity Disorder
O'Brien, L. M., Ivanenko, A., Crabtree, V. M., Holbrook, C. R., Bruner, J. L., Klaus, C. J., & Gozal, D. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000072333.11711.9a · Cited by 172 · see citing works
Popa, D., Léna, C., Fabre, V., Prenat, C., Gingrich, J. A., Escourrou, P., Hamon, M., & Adrien, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1724-05.2005 · Cited by 170 · see citing works
Neuroanatomy and neurochemistry of sleep
Stenberg, D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6530-3 · Cited by 151 · see citing works
Sleep attacks (sleep episodes) with pergolide
Schapira, A. H. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02118-8 · Cited by 130 · see citing works
Orexin Neurons Are Directly and Indirectly Regulated by Catecholamines in a Complex Manner
Yamanaka, A., Muraki, Y., Ichiki, K., Tsujino, N., Kilduff, T. S., Goto, K., & Sakurai, T. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01361.2005 · Cited by 122 · see citing works
Rye, D. B. (2004) · Neurology · doi:10.1212/wnl.63.8_suppl_3.s2 · Cited by 108 · see citing works
Dopaminergic regulation of orexin neurons
Bubser, M., Fadel, J. R., Jackson, L. L., Meador‐Woodruff, J. H., Jing, D., & Deutch, A. Y. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04121.x · Cited by 96 · see citing works
Monaca, C. C., Boutrel, B., Hen, R., Hamon, M., & Adrien, J. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300109 · Cited by 90 · see citing works
Self-citationRegulation of Macrophage Gene Expression by the Peroxisome Proliferator-Activated Receptor-γ
Ricote, M., Welch, J. S., & Glass, C. K. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053271 · Cited by 88 · see citing works
Ongini, E., Bonizzoni, E., Ferri, N., Milani, S., & Trampus, M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38367-9 · Cited by 87 · see citing works
Andreu, N., Chalé, J.-J., Sénard, J., Thalamas, C., Montastruc, J., & Rascol, O. (1999) · PubMed · Cited by 78 · see citing works
Andreu, N., Chalé, J.-J., Sénard, J., Thalamas, C., Montastruc, J., & Rascol, O. (1999) · Clinical Neuropharmacology · doi:10.1097/00002826-199901000-00004 · Cited by 76 · see citing works
Monti, J. M., Jantos, H., & Fernández, M. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90817-0 · Cited by 71 · see citing works
Trampus, M., Ferri, N., Adami, M., & Ongini, E. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90823-z · Cited by 71 · see citing works
Effect of ropinirole on sleep onset: A randomized, placebo-controlled study in healthy volunteers
Ferreira, J. J., Galitzky, M., Thalamas, C., Tiberge, M., Montastruc, J., Sampaio, C., & Rascol, O. (2002) · Neurology · doi:10.1212/wnl.58.3.460 · Cited by 69 · see citing works
Lagos, P., Scorza, C., Monti, J. M., Jantos, H., Reyes-Parada, M. I., Silveira, R., & Ponzoni, A. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00054-0 · Cited by 67 · see citing works
Vigilance troubles in Parkinson's disease: A subjective and objective polysomnographic study
Monaca, C. C., Duhamel, A., Jacquesson, J., Özsancak, C., Destée, A., Guieu, J. D., Defebvre, L., & Derambure, P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.12.002 · Cited by 65 · see citing works
Self-citationNocturnal sleep structure and temperature slope in MPTP treated monkeys
Almirall, H., Pigarev, I. N., de la Calzada, M. D., Pigareva, M. L., Herrero, M. T., & Sagalés, T. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050228 · Cited by 61 · see citing works
Vigilance states in a parkinsonian model, the MPTP mouse
Monaca, C. C., Laloux, C., Jacquesson, J., Gelé, P., Maréchal, X., Bordet, R., Destée, A., & Derambure, P. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03694.x · Cited by 60 · see citing works
Self-citationREM inhibitory effect of L-dopa infusion during human sleep
Gillin, J. C., Post, R. M., Wyatt, R. J., Goodwin, F. K., Snyder, F. R., & Bunney, W. E. (1973) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(73)90174-0 · Cited by 60 · see citing works
Sleep disturbances in the rotenone animal model of Parkinson disease
García‐García, F., Ponce, S., Brown, R. A., Cussen, V. A., & Krueger, J. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.036 · Cited by 45 · see citing works
Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients
Ferreira, J. J., Thalamas, C., Montastruc, J. L., Castro‐Caldas, A., & Rascol, O. (2001) · Journal of Neurology · doi:10.1007/s004150170188 · Cited by 42 · see citing works
Crochet, S., & Sakai, K. (2003) · SLEEP · doi:10.1093/sleep/26.7.801 · Cited by 42 · see citing works
Falling asleep at the wheel: Motor vehicle mishaps in people taking pramipexole and ropinirole
Olanow, C. W., Schapira, A. H. V., Roth, T. G., Weiner, W. J., Hoehn, M. M., Lledo, A., Nash, J., Arellano, F. M., Corrigan, M., Arnold, G., et al. (2000) · Neurology · doi:10.1212/wnl.54.1.274 · Cited by 37 · see citing works
A novel effect of MPTP: the selective suppression of paradoxical sleep in cats
Pungor, K., Papp, M. I., Kékesi, K. A., & Juhász, G. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)90880-k · Cited by 34 · see citing works
l -DOPA–induced excessive daytime sleepiness in PD
Garcı́a-Borreguero, D., Schwarz, C., Larrosa, O., de la Llave, Y., & de Yébenes, J. G. (2003) · Neurology · doi:10.1212/wnl.61.7.1008 · Cited by 30 · see citing works
Fuller, R. W., Clemens, J. A., & Hynes, M. D. (1982) · PubMed · Cited by 30 · see citing works
Fuller, R. W., Clemens, J. A., & Hynes, M. D. (1982) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198212000-00002 · Cited by 28 · see citing works
Effects of a D2 receptor agonist RO 41–9067 alone and with clonidine on sleep parameters in the rat
Python, A., Hilaire, Z. D. S., & Gaillard, J. M. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02023-3 · Cited by 19 · see citing works
Behavioural effects induced in rats and chicks by D2 dopamine agonists
Ferrari, F., & Giuliani, D. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90078-t · Cited by 17 · see citing works
Reduction in paradoxical sleep after l-dopa administration in rats
Galarraga, E., Corsi‐Cabrera, M., & Sangri, M. (1986) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(86)90170-6 · Cited by 9 · see citing works
Maggini, C., Guazzelli, M., Pieri, M., Lattanzi, L., Ciapparelli, A., Massimetti, G., & Rossi, C. (1986) · CINECA IRIS Institutial research information system (University of Pisa) · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P., Feyder, M. T., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 470 · see citing works
Circadian and sleep disorders in Parkinson's disease
Videnović, A., & Golombek, D. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.018 · Cited by 247 · see citing works
Behavioral phenotyping of mouse models of Parkinson's disease
Taylor, T. N., Greene, J. G., & Miller, G. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.004 · Cited by 198 · see citing works
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Hunt, J., Coulson, E. J., Rajnarayanan, R. V., Oster, H., Videnović, A., & Rawashdeh, O. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00504-w · Cited by 113 · see citing works
Pfeiffenberger, C., & Allada, R. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003003 · Cited by 111 · see citing works
Disrupted sleep and circadian rhythms in schizophrenia and their interaction with dopamine signaling
Ashton, A., & Jagannath, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00636 · Cited by 106 · see citing works
Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases
Rothman, S. M., & Mattson, M. P. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8181-2 · Cited by 102 · see citing works
Zoccolella, S., Savarese, M., Lamberti, P., Manni, R., Pacchetti, C., & Logroscino, G. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2010.02.004 · Cited by 101 · see citing works
Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep
Qiu, M., Yao, Q.-L., Vetrivelan, R., Chen, M. C., & Lu, J. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu241 · Cited by 89 · see citing works
Circadian dysregulation in Parkinson's disease
Videnovic, A., & Golombek, D. (2017) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2016.11.001 · Cited by 63 · see citing works
Are rodent models of Parkinson’s disease behaving as they should?
Vingill, S., Connor‐Robson, N., & Wade‐Martins, R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.021 · Cited by 60 · see citing works
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease
Chahine, L. M., Daley, J. T., Horn, S. S., Duda, J. E., Colcher, A., Hurtig, H. I., Cantor, C., & Dahodwala, N. A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.05.009 · Cited by 59 · see citing works
Han, N., Kim, Y.-K., Ahn, S., Hwang, T., Lee, H., & Park, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.599045 · Cited by 50 · see citing works
D1 receptor agonist improves sleep–wake parameters in experimental parkinsonism
Hyacinthe, C., Barraud, Q., Tison, F., Bézard, E., & Ghorayeb, I. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.029 · Cited by 44 · see citing works
MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations
Laloux, C., Derambure, P., Kreisler, A., Houdayer, E., Bruéziëre, S., Bordet, R., Destée, A., & Monaca, C. C. (2008) · Experimental Brain Research · doi:10.1007/s00221-008-1268-1 · Cited by 43 · see citing works
Self-citationScanga, A., Lafontaine, A., & Kamińska, M. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10450 · Cited by 37 · see citing works
Viaro, R., Marti, M., & Morari, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.01.014 · Cited by 31 · see citing works
Fifel, K., Piggins, H., & Deboer, T. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.02.005 · Cited by 30 · see citing works
Non-Motor Symptoms in Treated and Untreated Chinese Patients with Early Parkinson’s Disease
Zhang, H., Gu, Z., An, J., Wang, C., & Chan, P. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.232.129 · Cited by 27 · see citing works
Wang, C., & Zheng, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875349 · Cited by 22 · see citing works
Sleep disturbance by pramipexole is modified by Meis1 in mice
Salminen, A. V., Schormair, B., Flachskamm, C., Torres, M., Müller‐Myhsok, B., Kimura, M., & Winkelmann, J. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12557 · Cited by 16 · see citing works
Nigrostriatal and mesolimbic control of sleep–wake behavior in rat
Qiu, M., Zhong, Z., Chen, M. C., & Lu, J. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01921-w · Cited by 16 · see citing works
Sang-Bin, L. E. E., & Yang, H. O. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.020 · Cited by 15 · see citing works
Ando, R., Choudhury, M. E., Yamanishi, Y., Kyaw, W. T., Kubo, M., Kannou, M., Nishikawa, N., Tanaka, J., Nomoto, M., & Nagai, M. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.03.005 · Cited by 15 · see citing works
Gomes, T., Benedetti, A., Lafontaine, A., Kimoff, R. J., Robinson, A. R., & Kamińska, M. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10262 · Cited by 14 · see citing works
Impaired wakefulness and rapid eye movement sleep in dopamine-deficient mice
Kashiwagi, M., Kanuka, M., Tanaka, K., Fujita, M., Nakai, A., Tatsuzawa, C., Kobayashi, K., Ikeda, K., & Hayashi, Y. (2021) · Molecular Brain · doi:10.1186/s13041-021-00879-3 · Cited by 14 · see citing works
Inflaming the diseased brain: a role for tainted melanins
Jeitner, T. M., Kalogiannis, M., Patrick, P. A., Gomolin, I. H., Palaia, T. A., Ragolia, L., Brand, D. A., & Delikatny, E. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.004 · Cited by 13 · see citing works
Ukraintseva, Y. V., & Kovalzon, V. M. (2016) · Human Physiology · doi:10.1134/s0362119716050170 · Cited by 7 · see citing works
Methods and Models of the Nonmotor Symptoms of Parkinson Disease
McDonald, M. P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00023-8 · Cited by 6 · see citing works
Sleep disorders and Parkinson’s disease: is there a right direction?
Salsone, M., Agosta, F., Filippi, M., & Ferini‐Strambi, L. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12609-5 · Cited by 5 · see citing works
Seadawy, S. A. M., El-Shamarka, M. E.-S., Afify, M., Abdel‐Salam, O. M. E., & abouefadle, D. (2020) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2020.47734.2975 · Cited by 5 · see citing works
Subramanian, K. (2013) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2 · see citing works
CNS Disease from Toxins, Alcohol, and Cannabis: Effects on Sleep
Poceta, J. S., Dawson, A., & Shadan, F. F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378610-4.00469-1 · Cited by 2 · see citing works
Wu, D., He, J., Li, K., Liu, H., Jin, Y., Du, W., Ma, X., Long, Y., Li, S., Su, W., et al. (2023) · European Neurology · doi:10.1159/000533905 · Cited by 1 · see citing works
Neuroinflammation, sleep, and autoimmune disease
Zielinski, M. R., & Gibbons, A. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.00312-1 · Cited by 1 · see citing works
Chahine, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-67374-7.00001-8
Brief reference on sleep staging
Chahine, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-67374-7.00013-4
CNS disease from toxins, alcohol and cannabis: effects on sleep
Hsu, N. Y.-H., Dawson, A., & Poceta, J. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.00251-6
Additional file 1 of Impaired wakefulness and rapid eye movement sleep in dopamine-deficient mice
Kashiwagi, M., Kanuka, M., Tanaka, K., Fujita, M., Nakai, A., Tatsuzawa, C., Kobayashi, K., Ikeda, K., & Hayashi, Y. (2021) · Figshare · doi:10.6084/m9.figshare.17046972
- Authors
- LALOUX, C., DERAMBURE, P., HOUDAYER, E., JACQUESSON, J., BORDET, R., DESTÉE, A., & MONACA, C.
- Affiliations
- Centre Hospitalier Universitaire de Lille (FR)
- Corresponding author
- DERAMBURE, PHILIPPE
- Venue
- Journal of Sleep Research
- Publisher
- Wiley
- Published
- 2008-02-11
- Volume
- 17
- Issue
- 1
- Pages
- 101-110
- ISSN
- 0962-1105 (ISSN-L)
- 1365-2869
- OpenAlex
- W1991541555
- Cited by
- 40
- References
- 55
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Sleep Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- Parkinson's disease, MPTP, dopamine depletion, levodopa, pergolide, lisuride, dopamine D2 receptor agonist, wakefulness, dopaminergic neuron loss, Parkinson's disease model
- MeSH terms
- Animals, Electroencephalography, Levodopa, Lisuride, Male, Mice, Inbred C57BL, Pergolide, Sleep, Wakefulness, Polysomnography, Dopamine Agonists, Parkinsonian Disorders, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
